Search on Site

Explore our comprehensive database of pharmaceutical news releases, press releases, events, and industry insights with ease. Effortlessly find relevant information tailored to your interests and stay updated on the latest developments in the pharmaceutical sector. Start searching now to uncover valuable insights and resources for your pharmaceutical endeavors.

Peer-Reviewed Study in Obesity Pillars Further Substantiates Cardiovascular Safety Profile of CONTRAVE®/MYSIMBA, according to Currax Pharmaceuticals

settings. The latest analysis builds upon prior research, including the LIGHT trial, and complements the ongoing INFORMUS trial, a large-scale cardiovascular outcomes study, which now has enrolled more than 3,000 patients and is designed to meet...

Viking Therapeutics and CordenPharma Sign Long-Term Strategic Partnership for Integrated Supply of GLP-1 Peptides, Injectables, and Oral Formulations

Agonist, across the full supply chain from drug substance to drug product for both its subcutaneous and oral peptide formulations. CordenPharma is committed to ensuring seamless development and commercialization of Viking Therapeutics' VK2735 drug...

Kenox Pharmaceuticals announces a strategic collaboration with Lactiga to advance immunotherapy targeting mucosal areas

designed to enhance mucosal immunity in individuals with compromised immune systems. The grant will advance Lactiga's platform sIgA technology while expanding Kenox's capabilities in inhaled and intranasal biologic delivery systems. "We are...

At AAD 2025, five-year data for BIMZELX® (bimekizumab-bkzx) demonstrated sustained skin clearance and long-term efficacy in moderate-to-severe plaque psoriasis

Head of Patient Evidence, UCB. "These five-year results highlight the robust potential of bimekizumab-bkzx in transforming patient outcomes by offering the possibility of lasting, complete skin clearance. Bimekizumab-bkzx is aiming to set a new...

MedaSystems secures additional seed financing to advance its AI-driven workflow platform, expanding access and supporting investigator-initiated studies

MedaSystems, the leading SaaS platform for Expanded Access (EA) and Investigator-Initiated Studies (IIS), announced additional funding from existing investors, Debiopharm Innovation Fund, Nina Capital, and Young Sohn, a co-founder of Veeva...

Newly-formed Archerfish Precision Diagnostics Pte Ltd ushers in a new era in advanced diagnostics

Angsana Molecular & Diagnostics Laboratory (Angsana) and Pathnova Laboratories (Pathnova) have announced their merger to form Archerfish Precision Diagnostics Private Limited (Archerfish). This strategic union brings together two leading laboratory...

Shorla Oncology Announces the Launch of Dedicated Sales Force and Market Access Teams as Part of Expansion of Its U.S. Commercial Footprint

of a dedicated sales force and market access teams and the commercial availability of IMKELDI, the first oral liquid form of imatinib to treat certain forms of leukemia and other cancers. "The launch of our sales force and market access teams is a...

"Latigo Biotherapeutics has been granted FDA Fast Track Designation for LTG-001, a potential best-in-class Nav1.8 inhibitor for the non-opioid treatment of acute pain

for LTG-001. "We are pleased the FDA has granted Fast Track designation to LTG-001, recognizing its potential to transform the treatment landscape for acute pain by targeting pain at its source," said Nima Farzan, chief executive officer of Latigo....

Dr. Scott Grady Makes Thyroid RFA More Accessible in Oregon

plans, and patients are encouraged to check with their provider regarding eligibility. The in-office procedure is performed under local anesthesia, typically lasting 30–60 minutes, depending on the size of the nodule. Patients remain under...

TOOsonix Partners with MikronMed to Introduce Innovative Dermatological Therapy in the Nordic Region

the potential impact: "The Nordic dermatology market is growing, and TOOsonix's breakthrough technology is set to transform care for both clinicians and patients. Our extensive network and expertise in the Nordic healthcare sector, combined with...

Cellino Launches the U.S.’s First Nebula-Powered iPSC Foundry for Scalable Autologous Biomanufacturing

patient-specific stem cells. Located at Massachusetts General Hospital, the Foundry will leverage the Nebula platform to produce clinical-grade iPSCs and derivative therapies with unmatched precision and scalability for clinical-grade...

Vector Laboratories Appoints Ashley Scholz as Vice President of Marketing

as Head of Americas Marketing for Gore Medical. She successfully drove a marketing reorganization during a pivotal transformation while achieving 100% team retention. She also developed a cross-functional growth funnel process that uncovered $118...

LabConnect and Australian Clinical Labs' Specialised Trials Announce a Strategic Partnership in the Australia and Asia Pacific Region

sites in their clinical development plans and our partnership with ACL Specialised Trials provides us with a platform from which we can deliver our comprehensive suite of industry-leading central laboratory services across the region." About ACL...

Regemat 3D to Distribute VitroInk® Bioinks in Europe: A Strategic Move for Advanced Bioprinting Solutions

and clinical applications and how VitroGel® can help researchers improve personalized medicine globally. For more information please visit, www.thewellbio.com

A convenient and cost-effective way to treat sickle cell disease may be offered by Vascarta's patented transdermal drug candidate

et al. describes studies in which humanized sickle cell mice topically treated with Vascarta's transdermal curcumin gel formulation ("VAS-101") experienced reduced pain and inflammation along with improved red blood cell stability and...

PointClickCare Integration Announced by AccessDx Laboratory

diagnostics solutions, today announced its expanded integration with PointClickCare, a leading healthcare technology platform enabling meaningful care collaboration and real-time patient insights. This integration allows for the seamless delivery...

MAYPHARM CO., LTD. launches SKINCOLLA, the world's first recombinant human collagen filler for superior skin rejuvenation

Acid (HA), providing immediate and lasting improvements to skin texture, elasticity, and hydration. This cutting-edge formula mimics the body's natural collagen, restoring firmness, smoothness, and addressing common signs of aging such as wrinkles,...

Fosun Pharma deeply embraces AI, with its self-developed PharmAID Decision Intelligence Platform boosting efficient innovation

As a global innovation-driven pharmaceutical and healthcare group, Fosun Pharma places great emphasis on the transformative potential of AI technology in the pharmaceutical and healthcare sectors. The company actively embraces AI technology,...

Legacy Pharmacy Group (LPG) and Independent Pharmacy Cooperative (IPC) announce a strategic cooperation agreement

members with critical insights, legislative updates, and additional advocacy efforts. Together, we will champion PBM reform, protect pharmacist provider status and defend patient access to cost effective medications at community pharmacies. LPG...

Fresenius Kabi Launches Calcitonin Salmon Injection, USP Synthetic

postmenopausal osteoporosis when alternative treatments are not suitable. Fresenius Kabi Calcitonin Salmon Injection is formulated, filled and packaged in the United States. Available in 400 I.U./2 mL (200 I.U./mL) vials, the new product adds to...